BridgeMD
New treatment option for Seroma Following Procedure
Official title Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
ClinicalTrials.gov ID: NCT05280353
What this study is testing
- What it's testing
- Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Over 18 years old
- Conservative surgery for breast cancer with associated axillary lymphadenectomy
You likely can't join if
- Mastectomy
- History of axillary surgery or ipsilateral axillary radiotherapy
- ASA 4 patients. (ASA 3 patients selected)
- Lack of adequate cognitive capacity and/or signed informed consent
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Mataró, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mataró, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.